In yesterday’s Wall Street session, Clover Health Investments Corp (NASDAQ:CLOV) shares traded at $4.00, down -4.31% from the previous session.
CLOV stock price is now 28.11% away from the 50-day moving average and 157.13% away from the 200-day moving average. The market capitalization of the company currently stands at $1.99B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $4, UBS recently initiated with Neutral rating for Clover Health Investments Corp (NASDAQ: CLOV). On February 02, 2022, Cowen Upgraded its previous ‘Underperform’ rating to ‘Market Perform’ on the stock reducing its target price from $7 to quote $3, while ‘Canaccord Genuity’ rates the stock as ‘Buy’
In other news, Garipalli Vivek, Director bought 531,700 shares of the company’s stock on Aug 09 ’24. The stock was bought for $999,596 at an average price of $1.88. Upon completion of the transaction, the Director now directly owns 1,409,267 shares in the company, valued at $5.64 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 17 ’24, Director Garipalli Vivek bought 877,567 shares of the business’s stock. A total of $1,000,426 was incurred on buying the stock at an average price of $1.14. This leaves the insider owning 877,567 shares of the company worth $3.51 million. A total of 24.49% of the company’s stock is owned by insiders.
During the past 12 months, Clover Health Investments Corp has had a low of $0.61 and a high of $4.71. The fifty day moving average price for CLOV is $3.1223 and a two-hundred day moving average price translates $1.55566 for the stock.
The latest earnings results from Clover Health Investments Corp (NASDAQ: CLOV) was released for 2024-06-30. The net profit margin was -7.32% and return on equity was -39.04% for CLOV. The company reported revenue of $356.26 million for the quarter, compared to $320.14 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 11.28 percent.
